Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Clinical Study Comparing Triple Therapy Regimen to Hydrocortisone Monotherapy in Reducing Mortality in Septic Shock Patients

NCT04508946 is registered in ClinicalTrials.gov with Air Force Specialized Hospital, Cairo, Egypt as lead sponsor.

NCT NCT04508946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04508946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Clinical Study Comparing Triple Therapy Regimen to Hydrocortisone Monotherapy in Reducing Mortality in Septic Shock Patients
Lead sponsor
Air Force Specialized Hospital, Cairo, Egypt
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2019
Completion date
November 9, 2020
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

organ dysfunction syndrome sepsis, sepsis, septic shock